MF
TARO

Magnetar Financial’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Magnetar Financial’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,243
Closed -$515K – 528
2018
Q3 		$515K Buy
5,243
+2,873
+121% +$311K 0.01% 195
2018
Q2 		$274K Buy
+2,370
New +$260K ﹤0.01% 400
2016
Q4 		– Sell
-3,685
Closed -$407K – 405
2016
Q3 		$407K Buy
+3,685
New +$488K 0.01% 409

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Magnetar Financial's TARO Position: Q4 2018 in Review

Magnetar Financial sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 5,243 shares — an estimated $515K sold.

Magnetar Financial first reported a position in TARO in Q3 2016 and held it in 3 quarters. The position peaked at $515K in Q3 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

  • Magnetar Financial reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
  • Magnetar Financial sold 5,243 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $515K.
  • Magnetar Financial first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 3 quarters.
  • Magnetar Financial's Taro Pharmaceutical Industries Ltd. position peaked at $515K in Q3 2018.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on Magnetar Financial's 13F filing for Q4 2018, filed 14 Feb 2019.